MedTrace Logo

Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery

NCT02576223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-03-21

No results posted yet for this study

Summary

The purpose of this randomized study is to examine the effect of a selective suprascapular nerve block on post operative pain after arthroscopic shoulder surgery. Half of the subjects will receive a active nerve block with Ropivacain. Half of the subjects will receive a placebo nerve block with saline.

Conditions

Interventions

DRUG

Ropivacaine hydrochloride

Ropivacaine injected perineural at the suprascapular nerve.

DRUG

Isotonic Saline

Saline injected perineural at the suprascapular nerve.

DRUG

PCA-pump

PCA (Patient controlled analgesia) pump with the following settings: Age \> 70 years or weight \< 60 kg: bolus dose 2,5 mg i.v. morphine, 15 minutes lockout Age \< 70 years and weight \> 60 kg: bolus dose 5 mg i.v. morphine, 15 minutes lockout Lockout time 15 minutes.

Sponsors & Collaborators

  • Kai Henrik Wiborg Lange

    lead OTHER

Principal Investigators

  • Christian Steen-Hansen · Nordsjaellands Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-08-27
Completion
2018-08-27

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576223 on ClinicalTrials.gov